文献速递角膜与眼表疾病

吴茱萸碱通过p53/mTOR通路促进自噬并缓解干眼病氧化应激

Evodiamine Promotes Autophagy and Alleviates Oxidative Stress in Dry Eye Disease Through the p53/mTOR Pathway.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究探讨吴茱萸碱(EVO)对干眼病(DED)的治疗作用。采用苯扎氯铵滴眼液和皮下注射阿托品建立小鼠DED模型,体外以富钠培养基培养人角膜上皮细胞。EVO滴眼液显著增加小鼠泪液分泌、改善眼表损伤、降低角膜炎症因子表达并增加结膜杯状细胞密度,且通过p53/雷帕霉素靶蛋白通路促进自噬减轻氧化应激;作者认为EVO是DED的潜在治疗药物。

要点

  • EVO滴眼液显著增加DED小鼠泪液分泌并改善眼表损伤。
  • EVO降低角膜炎症因子表达并增加结膜杯状细胞密度。
  • EVO通过p53/mTOR通路促进自噬以减轻氧化应激。

核心结论

  • 作者认为EVO是治疗DED的潜在药物,其有益效应归因于通过p53/雷帕霉素靶蛋白通路激活自噬。

研究设计与样本

  • 研究采用苯扎氯铵滴眼液和皮下注射阿托品建立小鼠DED模型,并以富钠培养基培养人角膜上皮细胞建立体外模型。

主要发现

  • EVO滴眼液显著增强小鼠泪液分泌、改善眼表损伤、降低角膜炎症因子表达并增加结膜杯状细胞密度。
  • EVO通过促进自噬减少氧化应激。
  • EVO诱导的自噬由p53/雷帕霉素靶蛋白通路介导。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to explore the therapeutic efficacy of evodiamine (EVO) in the treatment of dry eye disease (DED). METHODS: Mouse models of DED was developed using benzalkonium chloride eye drops and subcutaneous atropine injections. Corneal epithelial defects were assessed by fluorescein sodium staining, and tear secretion was measured with the phenol red thread test. For the in vitro model, human corneal epithelial cells were cultured in a sodium chloride-enriched medium. Phenotypic and mechanistic analyses were conducted using real-time quantitative PCR, Western blotting, flow cytometry, and immunofluorescence staining. RESULTS: The administration of EVO eye drops significantly enhanced tear secretion in mice, ameliorated ocular surface damage, decreased the expression of corneal inflammatory factors, and increased the density of conjunctival goblet cells. Furthermore, EVO reduced oxidative stress by promoting autophagy. Mechanistically, EVO-induced autophagy was mediated via the p53/mammalian target of rapamycin pathway. CONCLUSIONS: These findings suggest that EVO is a potential therapeutic agent for the treatment of DED, with its beneficial effects attributed to the activation of autophagy through the p53/mammalian target of rapamycin pathway.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Li B, Liu J, Zhang D, et al. Evodiamine Promotes Autophagy and Alleviates Oxidative Stress in Dry Eye Disease Through the p53/mTOR Pathway. Invest Ophthalmol Vis Sci. 2025. PMID: 40111353. doi:10.1167/iovs.66.3.44

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。